Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors
Replimune Inc.
Replimune Inc.
Carevive Systems, Inc.
University of Oklahoma
M.D. Anderson Cancer Center
Varian, a Siemens Healthineers Company
BicycleTx Limited
City of Hope Medical Center
Tempus AI
Revolution Medicines, Inc.